Skip to main content
logo
Novakand Pharma AB (publ) (FRA:3EE0)
Germany flag Germany · Delayed Price · Currency is EUR
0.0001
0.00 (0.00%)
Last updated: Feb 23, 2026, 8:21 AM CET

Novakand Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
16.0746.3645.6995.15106.52
Cash & Short-Term Investments
16.0746.3645.6995.15106.52
Cash Growth
-65.33%1.47%-51.98%-10.68%93.65%
Accounts Receivable
----5.28
Other Receivables
0.431.541.240.86-
Receivables
0.431.541.240.865.28
Prepaid Expenses
0.231.010.710.97-
Other Current Assets
---2.51-
Total Current Assets
16.7348.9147.6499.49111.8
Property, Plant & Equipment
---0.250.61
Long-Term Investments
00000
Other Intangible Assets
-18182121
Other Long-Term Assets
-----0
Total Assets
16.7366.9165.64120.74133.41
Accounts Payable
-2.672.753.333.6
Accrued Expenses
0.861.2814.666.746.7
Current Portion of Leases
----0.13
Other Current Liabilities
0.810.670.573.76-
Total Current Liabilities
1.674.6117.9813.8310.43
Long-Term Leases
----0.44
Other Long-Term Liabilities
-0----0
Total Liabilities
1.674.6117.9813.8310.87
Common Stock
15.0711.787.9266.2746.79
Additional Paid-In Capital
-460.92405.57401.58384.21
Retained Earnings
--410.4-365.83-360.94-308.46
Comprehensive Income & Other
---0-0
Shareholders' Equity
15.0762.347.67106.91122.54
Total Liabilities & Equity
16.7366.9165.64120.74133.41
Total Debt
----0.57
Net Cash (Debt)
16.0746.3645.6995.15105.95
Net Cash Growth
-65.33%1.47%-51.98%-10.20%97.36%
Net Cash Per Share
0.130.400.571.641.89
Filing Date Shares Outstanding
121.19121.1981.5179.5356.14
Total Common Shares Outstanding
121.19121.1981.5179.5356.14
Working Capital
15.0644.329.6685.66101.37
Book Value Per Share
0.120.510.581.342.18
Tangible Book Value
15.0744.329.6785.91101.54
Tangible Book Value Per Share
0.120.370.361.081.81
Machinery
---0.060.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.